| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/15/2002 | WO2001085153A3 Potentiation of antineoplastic agents using sigma-2 ligands |
| 08/15/2002 | WO2001083526A3 Calcitonin-related molecules |
| 08/15/2002 | WO2001079246A3 3'-or 2'-hydroxymethyl substituted nucleoside derivatives for treatment of hepatitis virus infections |
| 08/15/2002 | WO2001077177A3 Gpcr-proteins and nucleic acids encoding same |
| 08/15/2002 | WO2001072825A3 Apoptin-associating protein |
| 08/15/2002 | WO2001072824A3 Apoptin-associating protein |
| 08/15/2002 | WO2001066713A8 Activation of pure prothrombin to thrombin with sodium citrate |
| 08/15/2002 | WO2001066572A9 Polynucleotides isolated from e. coli of nature b2/d+ a-, and uses thereof |
| 08/15/2002 | WO2001057079A3 C1 inhibitor produced in the milk of transgenic mammals |
| 08/15/2002 | WO2001034801A9 Recombinant gelatin in vaccines |
| 08/15/2002 | WO2001034625A9 Isolation and characterization of human nf-e4 |
| 08/15/2002 | WO2001032843A9 Enhanced immune recognition of pathogenic cells by icsbp expression |
| 08/15/2002 | WO2001032222A9 Selective toxin expression in angiogenic endothelial cells |
| 08/15/2002 | WO2001019856A3 Secreted human proteins, polynucleotides encoding them and methods of using the same |
| 08/15/2002 | WO2001016182A3 POLYPEPTIDES THAT BIND HIV gp120 AND RELATED NUCLEIC ACIDS, ANTIBODIES, COMPOSITIONS, AND METHODS OF USE |
| 08/15/2002 | WO2001013935A3 Modulation of the blood-brain barrier transporter for leptin |
| 08/15/2002 | WO2000008048A3 Inhibitor of histone deacetylase |
| 08/15/2002 | US20020112251 Nuclelotide sequences for use in the treatment proliferative defects |
| 08/15/2002 | US20020112026 Apparatuses, methods, and computer programs for displaying information on signs |
| 08/15/2002 | US20020111475 Flt3-L mutants and methods of use |
| 08/15/2002 | US20020111469 Polypeptide for use in the treatment of tumors, lung defects, inflammation and heart defects |
| 08/15/2002 | US20020111467 Compositions and methods for the treatment and diagnosis of breast cancer |
| 08/15/2002 | US20020111464 Diagnostic kit for detecting microorganismal infections in animals |
| 08/15/2002 | US20020111462 Nuclelotide sequences coding peptide for use in the treatment of autoimmune diseases |
| 08/15/2002 | US20020111461 Peptidomimetic compound for us ein the treatment of diabetes |
| 08/15/2002 | US20020111460 Polypeptide for use in the treatment of blood coagulation, proteolysis, complement activation, fertilization, and hormone generation defects; for use as wound healing agents |
| 08/15/2002 | US20020111368 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 08/15/2002 | US20020111349 Method for treatment and prevention of mastitis |
| 08/15/2002 | US20020111347 Nervous system disorders |
| 08/15/2002 | US20020111343 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-Amyloid peptide release and/or its synthesis by use of such compounds |
| 08/15/2002 | US20020111341 Bicyclic amino-pyrazinone compounds |
| 08/15/2002 | US20020111338 Bile-acid conjugates for providing sustained systemic concentrations of drugs |
| 08/15/2002 | US20020111331 FGF-affinity chromatography |
| 08/15/2002 | US20020111325 VEGI, an inhibitor of angiogenesis and tumor growth |
| 08/15/2002 | US20020111324 Adeno-associated virus-mediated delivery of angiogenic factors |
| 08/15/2002 | US20020111323 Genetic engineering |
| 08/15/2002 | US20020111315 Synergistic mixture with antilipemic agent |
| 08/15/2002 | US20020111314 Novel stimulation of gene expression and protein synthesis of heat shock protein 72/73 (Hsp 70) |
| 08/15/2002 | US20020111313 Tripeptide dosage |
| 08/15/2002 | US20020111312 Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients |
| 08/15/2002 | US20020111311 Antibiotics |
| 08/15/2002 | US20020111310 25219, a novel human aminotransferase and uses therefor |
| 08/15/2002 | US20020111309 Therapeutic applications of laminin and laminin-derived protein fragments |
| 08/15/2002 | US20020111308 Compositions and methods for the therapy and diagnosis of pancreatic cancer |
| 08/15/2002 | US20020111305 Antiviral peptides |
| 08/15/2002 | US20020111304 Methods and compositions for treating fibrotic diseases |
| 08/15/2002 | US20020111302 Novel nucleic acids and polypeptides |
| 08/15/2002 | US20020111301 Administering polypeptide mixture |
| 08/15/2002 | US20020111300 Methods for reduced renal uptake of protein conjugates |
| 08/15/2002 | US20020111299 Family of peptides known as xenoxins |
| 08/15/2002 | US20020111297 Method of using lectins for therapy of diseases transmittable by sexual contact |
| 08/15/2002 | US20020111296 Thrombomodulin analogs for use in recovery of spinal cord injury |
| 08/15/2002 | US20020111295 Agents for alleviating symptoms accompanied by inflammation |
| 08/15/2002 | US20020111294 Administering an organocobalt complex |
| 08/15/2002 | US20020111293 Modulator of tyrosine kinase receptors |
| 08/15/2002 | US20020111292 Bone disorders, alopesia |
| 08/15/2002 | US20020111290 Calibration of chemokine or receptor expression; medical diagnosis |
| 08/15/2002 | US20020111146 Apparatuses, methods, and computer programs for displaying information on signs |
| 08/15/2002 | US20020110913 Human cell culture for use in the generation of erythropoietin |
| 08/15/2002 | US20020110908 Novel human kinases and polynucleotides encoding the same |
| 08/15/2002 | US20020110895 Nucleotide sequences coding enzymatic polypeptide for use in treatment of thrombosis and in the immune defects |
| 08/15/2002 | US20020110893 Novel human bcl-x-like proteins and polynucleotides encoding the same |
| 08/15/2002 | US20020110892 Human RNase H and compositions and uses thereof |
| 08/15/2002 | US20020110889 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 08/15/2002 | US20020110872 Cytotoxic factors for modulating cell death |
| 08/15/2002 | US20020110870 Therapeutic applications for CCR5 chemokine receptors |
| 08/15/2002 | US20020110868 Tumor necrosis factor ptotein; for use in the treatment of rheumatic diseases and arthritis |
| 08/15/2002 | US20020110867 Cardiac and pancreatic protein and gene |
| 08/15/2002 | US20020110866 Nucleotide sequences coding viral capsid protein; for use in the diagnosis, treatment and/or vaccination |
| 08/15/2002 | US20020110865 Papilloma viruses, agents for detecting them and for treating diseases caused by such viruses |
| 08/15/2002 | US20020110864 Polypeptide and DNAs encoding it |
| 08/15/2002 | US20020110862 Novel Siglec-like gene |
| 08/15/2002 | US20020110859 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/15/2002 | US20020110858 Lymphocytic membrane proteins |
| 08/15/2002 | US20020110853 Polypeptide; for use in the treatment of tumors |
| 08/15/2002 | US20020110852 Peptide; for use in the treatment of pancreatic defects |
| 08/15/2002 | US20020110851 Polypeptide for use in treatment of cancer, vascular, liver, autoimmune and nervous system disorders |
| 08/15/2002 | US20020110841 Regulation of cell growth by MUC1 |
| 08/15/2002 | US20020110832 Compositions and methods for the therapy and diagnosis of colon cancer |
| 08/15/2002 | US20020110811 Variants of protein kinases |
| 08/15/2002 | US20020110805 Peptide for use in the treatment of glomerulonephritis, psoriasis, leukemia, antherosclerosis, autoimmune diseases, inflammatory, arthritic, asthmatic, and fibrotic disorders |
| 08/15/2002 | US20020110601 Antineoplastic platinum therapeutic method and composition |
| 08/15/2002 | US20020110566 Administering fusion protein comprising a heat shock protein (hsp) or an immunostimulatory fragment thereof, and protein of a human papilloma virus (HPV), or an antigenic fragment thereof, for therapy of wart |
| 08/15/2002 | US20020110561 For use in therapy, sustained release of drugs |
| 08/15/2002 | US20020110560 Lowering elevated post-prandial blood glucose levels in mammals by increasing incretin half-life comprising administering inhibitor of Dipeptidyl Peptidase (DP IV) or enzymes having DP-IV-like activity |
| 08/15/2002 | US20020110559 Confering an immune response to a tumor cell in a mammal by administering antibody which binds to aspartyl (asparaginyl) beta hydroxylase (HAAH) |
| 08/15/2002 | US20020110558 For therapy |
| 08/15/2002 | US20020110557 Cyanovirin conjugates and matrix-anchored cyanovirin and related compositions and methods of use |
| 08/15/2002 | US20020110553 Use of antibiotic peptides produced by human corneal epithelial cells to manage infection |
| 08/15/2002 | US20020110552 Stabilized liquid preparation of the protease which activates blood coagulation factor VII, or of its proenzyme |
| 08/15/2002 | US20020110551 Administering to the individual therapeutically effective amount of human acid alpha-glucosidase at regular interval for therapy of glycogen storage disease type II |
| 08/15/2002 | US20020110549 Presbyopia treatment by lens alteration |
| 08/15/2002 | US20020110547 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
| 08/15/2002 | US20020110546 Implanting cells of an immortalized human neuro-derived fetal cell line into the host for therapy |
| 08/15/2002 | US20020110545 Adenovector pharmaceutical composition |
| 08/15/2002 | US20020110543 Viral delivery system for infectious transfer of large genomic DNA inserts |
| 08/15/2002 | US20020110540 Disease prevention by reactivation of the thymus |
| 08/15/2002 | US20020110539 Modulated release particles for lung delivery |
| 08/15/2002 | US20020110538 Methods and products for tumor immunotherapy using cytokines |
| 08/15/2002 | US20020110535 Multivalent platform molecules comprising high molecular weight polyethylene oxide |